NCT06526104 2026-01-06
Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis
The University of Texas Health Science Center at San Antonio
Phase 2 Recruiting
Clinical Trials
9 trialsNCT06084234 2025-11-26
TRACER
University of Texas Southwestern Medical Center
Phase 4 Recruiting
NCT05971108 2025-09-24
REVISE-HCC
Manchester University NHS Foundation Trust
Phase NA Recruiting
NCT06015022 2025-09-05
CATCH-B
University of Texas Southwestern Medical Center
Phase 2 Recruiting
NCT05433467 2025-08-13
CTMH
Northern Jiangsu People's Hospital
Phase NA Recruiting
NCT06366425 2025-07-10
HEPGEN
University Hospital, Montpellier
Phase NA Recruiting
NCT07053488 2025-07-08
CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
Phase 1/2 Recruiting
NCT06338215 2024-12-12
UNATI
Clinica Universidad de Navarra, Universidad de Navarra
Phase NA Recruiting
NCT05304234 2024-06-04
Liver Cancer Disparities in American Indian and Alaska Native Persons
University of Washington
Phase 2 Recruiting